Kevin G. Lokay - Jun 16, 2021 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
Director
Signature
/s/ Christopher Degnan, Attorney-in-Fact for Kevin G. Lokay
Stock symbol
GRTX
Transactions as of
Jun 16, 2021
Transactions value $
$0
Form type
4
Date filed
6/17/2021, 06:42 PM
Next filing
Jun 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option (Right to Buy) Award $0 +9.89K $0.00 9.89K Jun 16, 2021 Common Stock 9.89K $8.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable on the earlier of June 16, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.